Bioplus Acquisition Corp Stock Fundamentals
BioPlus Acquisition Corp fundamentals help investors to digest information that contributes to BioPlus Acquisition's financial success or failures. It also enables traders to predict the movement of BioPlus Stock. The fundamental analysis module provides a way to measure BioPlus Acquisition's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioPlus Acquisition stock.
BioPlus |
BioPlus Acquisition Corp Company Shares Owned By Insiders Analysis
BioPlus Acquisition's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current BioPlus Acquisition Shares Owned By Insiders | 48.69 % |
Most of BioPlus Acquisition's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioPlus Acquisition Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 48.687% of BioPlus Acquisition Corp are shares owned by insiders. This is much higher than that of the Capital Markets sector and significantly higher than that of the Financials industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
BioPlus Acquisition Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioPlus Acquisition's current stock value. Our valuation model uses many indicators to compare BioPlus Acquisition value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioPlus Acquisition competition to find correlations between indicators driving BioPlus Acquisition's intrinsic value. More Info.BioPlus Acquisition Corp is rated below average in return on asset category among its peers. It is rated third in current valuation category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value BioPlus Acquisition by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
All Next | Launch Module |
BioPlus Fundamentals
Return On Asset | -0.0072 | |||
Current Valuation | 215.16 M | |||
Shares Outstanding | 19.37 M | |||
Shares Owned By Insiders | 48.69 % | |||
Shares Owned By Institutions | 51.31 % | |||
Number Of Shares Shorted | 1.64 K | |||
Price To Earning | (3.62) X | |||
EBITDA | (1.17 M) | |||
Net Income | 2 M | |||
Cash And Equivalents | 294.69 K | |||
Cash Per Share | 0.01 X | |||
Total Debt | 5 M | |||
Debt To Equity | 7.23 % | |||
Current Ratio | 2.96 X | |||
Book Value Per Share | (0.86) X | |||
Cash Flow From Operations | (691.47 K) | |||
Short Ratio | 0.03 X | |||
Earnings Per Share | 0.21 X | |||
Price To Earnings To Growth | (7.93) X | |||
Target Price | 20.0 | |||
Number Of Employees | 38 | |||
Beta | 0.14 | |||
Market Capitalization | 208.98 M | |||
Total Asset | 238.32 M | |||
Retained Earnings | (14.78 M) | |||
Working Capital | 21.89 K | |||
Current Asset | 183.69 M | |||
Current Liabilities | 152.76 M | |||
Z Score | 24.97 | |||
Net Asset | 238.32 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in BioPlus Stock
If you are still planning to invest in BioPlus Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioPlus Acquisition's history and understand the potential risks before investing.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |